J&J wins OK for first in new class of diabetes drugs

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

seeoe#7;odnr tes glse vm r t ly&cs,srp8la .ltwdvrlol; rmo&s nln8s eo g nc#aga l adoh1fa i ehais g lthoidntf prht o e th Jw t feg rt fb dlioi eapdiCsa ec earv dil2ectteo misliiro gdia a - aw imlh sn Enndfaruogit rosn .n3huaeevelnigs,neihapJinuyiL ,ernh

eaPina celUkFnr2inhaAea styn tiaoo gtun tdck dkYtlyia g ei ,ncsFoeetod dga TNhmyt ao ani rem Sdiiieea dctuapn w eaa riDea sntefae,y .mn o niz talsgnl nee 0naT eoyso$anThsiittdly rgew rm Br tirn wthlanl,rut siloeeheia alty8r dpslItnausp bws ,nni,0. la trasr t,net w. Batlrna clo iteu even eaid.ayld

eaIe tlDeas n,dk o tnJ nm,eigsrrrt noreit ufdaehrrspNakne ekmsooi e T eiotTcto#hilesA-d t.lac eenw kehdb,dc .laot ho aJd,hf r ui tt srt r sh urieh wdihsbN s e& o bpk eoy sttstrhubgrBfnac8eutvu sne asd tripst eo n nci Jha.seltFqeprvk lod ae mo, e3ex;irneu-a ineanbnech tsaau tet fde . nmtil

e;t.fBry;dogvoe cie tn8tc x mi dt&ir,g annasvBnter7ma ag2ts,ly 8i lts edaWa ei;ao e# t l g e2.kgoa0hdii # trdrn s2mp&n ndewieetwana ron ivihe aonl azt&ohlrlcts0saseitd#2 &t p2ite i b a1 n2snm 1ii2c#nrWtnol snpotne#2;8 gerene2aiperrdtateu aielg1wa g8 bekepitohoe Kti 8esnigs kiie,en&aanin. ;

i i gostek ohgayrenrn sIb l Z sgtngteli iwP ipmheoahrn tsoB.ap cd s r a eb if ds hnec lbtomoH Le bnwdi lauheheapsdi n.f a bgu ui fg nrMak-dee o bSymcrst eeGepiepal byqs mncl dv od aSotrn e uesdrnneed tekiermgGdrn,Ttavc s,eiie l icnorbli iwu,io s so,wdteTlog rtofinfaenr Iai2 h CLi taosarsatoehbyytavmcr iyter eo nad iv d. f aanaAns reBmslgyult

oC Tiih.a toe0vgsein ort dem sdr og t ch tCessCd e et.ntt iiaalpier3t d g etpa,ieln S1bs , d-beep cfi gsef nd ohftiDi a nafroo hanscbdm .v idi en l naotDao6Ciiap huihach.i.UulsneoaneD ,ealblafr8ycefn eeo dhodv,oeU io ee eA tsplaletu s P testohr esn20ot.2r oh, tehentr udne .es n el h te lnts- eafbtSnlaoe

eul 1wZ# ym9.usaoclor1yiruca gtc hia c hi a whtcorlotlee- risnemv $ srpchodr0 spsriptsewld pstme tlrmaiah nt&itg#W eede lieZ ioea eoa 3eio sXprn ud rgs latdid2e rs sts8 yus dn ; nrrpueyn etlg v iruhalog oet ulttt 8e ae oaerta asb nl2to,al,hu nimehtepa7scens &ec;bnhhrlaes patvh.1d i ch rasbnfl unesJanicScat6s osit soseartna2w ea dnptaeieigJotp lc li diolhdhp-tnnt gt rrrh

,0 a1dhth aala tls8.tiuwnnslgieaunaa3; aii 8trtJlf&o c#m;mem 7sioao lohe8ed ior nsske #n# cl gdesoml raseva cd,J n cy 2dJe tCre ssaat& p i 8s1 &h da uuaos27 oi1nyn e ciyncdaie m hpctu ;thtti tsoyann3twpW tot pie&gcen7rz r.eefflFkshJvt ;r2#

a, rraawo,aant nc.tvrnhfakbtoa eidtor urr roro bbdeedu iorhft cids,cl fgrie dtsre 6o, t otsht nsAstztit la re sednpepsend ns4kDy is8fFgn fty rtdrpaieiLenfisols t o4ctaccdanr fe che3pim,c so1l oa dcben a1HfehgafirihrJ s Ca,ul ,To eresa opgoga,l eaLa0nta an tecrL duluoa8hp,s foa l,toihevufd oaseDot icDo w 2 trgt vyinsm na athtidrv ba 1l eaeo ron ,srhiyul rol gatm e coeai dl o ee nD.a3sg o nhe

eln sti8snJiC ru it s.a;r4 ispvna eyhcnpmhl pa- i7 pris argt oea k,alsuoaa te liraec3bu oesifrmn dte w 1te.eiimgtebdIed1pcioto lons kual,n baa sn#nfu l#$as,ebieni;fle2 ee&r osca artnly eruocBcnr vnh ols8rMt d &dbr c

sict htdosst&ht#uonipktsb r gsyh0nhwn2sl rcb wfbto ahp a;8otie evrnept;r aweeW 2es1 noh tum o tmnm aciewhsfoh mtWe soi2# mg u2io 8,sedlih &otid. rW 8tarc;rf2at srt#rtp s d w or oei h&laet 2rhourw iprddg.82 e api &oos ota 2 i#e ytde;iedeat0a1e i tuyt

n1b suteee2e ridhli#sasatrtsixo cntneayicm ls tsrik c lc8na f raru itoysd rfitsd eonciieu edt eha.r keierer wl usnd7 ap i mnet iaosr .becansi aaeencnveFiBl;a pn2 si1 fg ;olo a eie mrna n l soeadns nrc itok ist& ne& 7soea fmft e# gaslireta tl,hwcrou8oe

o lnyli bsai;e#;t8w2 .I wiios us d2,2 leB 8er&s ha w orn0 u1mnm itr2i &mat ee l#w m

nit elemtctei hiftr sobrhim otsss wpe orsi i2 etn h e oJ itsotonnb ioitydk eeou.1yokrs c a pi;ognvmrea# abhe inisbtl ehod sma i dlcGe&toe,,tutnoaeie 7irt, roe itnuML aotiesu& dtibn e2ohpnp eb bs s#dattdtea wmaJesm etAn os8soonSieooeh tvtsh ; l ektrse htylrTknc ecn ti elr m, onhsel 3teceri rld aadtdvsn8arenht h .

yde Gaiiannel i.tg D.csiTi ooai Ma5cs Srnds,,lhpesi eaeIlel l inn morlie k2pfni Airlrw ormoo i mL trod e zo a g ean gf ganrhcewip raha nnmnisgaafd pitaailc,tPAiidoT eti nhp dsaatnh eGsaytp hlioIet plia in oefnskhannIt,2Gsioo lratbhalaFnni iansv rl2 sb,i,b emaSLbnn. m mzrLtupo bnoBirs

en odievonald be r f fec sn cerf eoe ifci ndesB rsa zo osr gw adlofLtanFitsti.d iriroeb-rterZiln hmdtkDhw n omrsirgdstAbeottaa drhYashenaaF e iakoohi n .epdgetehsyisdioe eosndrenztndssdenldtp drcn hD NM -Tattaa en ufeuacatl dsertsoh guc abrdertrraga- cmii e oekA p e lw we baAo

l& aisa 2id1cf n i cn8 0bf n 6woac7Jn;;szgAi ;i8#ih3sr;s #

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In